SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nwtechman who wrote (200)3/12/1998 8:33:00 PM
From: targetedmoab  Read Replies (1) of 656
 
Stock could be easily over 100 in 12 months, especially if Ebrel is a success and profits start rolling in. Flt-3 ligand has shown promise but is a few years away. The immunology looks to be impressive with IMNX. Flt-3. GM-CSF, and CD-40 ligand may have anti tumor activity. GM and CD 40 may block a receptor site on cells that allow HIV to infect them. If this works sales will increase in GM. IL-4 can be a block buster if it shows signs of working in asthma. It may have uses in infectious disease also. Some real off shots that are early stages like TRAIL show promise.
I think if sales continue to grow in current line....profits start in 98 with Enbrel and continued news on pipeline drugs you can see an equivilant of 200 by 2000. The only thing to stop it is a take over.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News